Xtant Medical Holdings, Inc. (XTNT)
Largest Insider Buys in Sector
XTNT Stock Price History Chart
XTNT Stock Performance
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Insider Activity of Xtant Medical Holdings, Inc.
Over the last 12 months, insiders at Xtant Medical Holdings, Inc. have bought $49,837 and sold $0 worth of Xtant Medical Holdings, Inc. stock.
On average, over the past 5 years, insiders at Xtant Medical Holdings, Inc. have bought $568,485 and sold $100,888 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Brandt Kevin D (Chief Commercial Officer) — $49,837.
The last purchase of 41,670 shares for transaction amount of $49,837 was made by Brandt Kevin D (Chief Commercial Officer) on 2023‑11‑17.
List of Insider Buy and Sell Transactions, Xtant Medical Holdings, Inc.
| 2023-11-17 | Brandt Kevin D | Chief Commercial Officer | 41,670 0.0341% | $1.20 | $49,837 | -7.49% | ||
| 2023-01-18 | Sale | Neils Scott C | Chief Financial Officer | 8,673 0.0082% | $0.61 | $5,283 | +55.93% | |
| 2022-10-19 | Sale | Browne Sean E | President and CEO | 51,100 0.0471% | $0.62 | $31,820 | +9.68% | |
| 2022-10-18 | Sale | Browne Sean E | President and CEO | 80,000 0.0763% | $0.68 | $54,008 | +4.62% | |
| 2022-10-07 | Vizirgianakis Stavros G. | director | 2.26M 1.4161% | $0.48 | $1.09M | -4.23% | ||
| 2022-08-15 | Sale | Brandt Kevin D | Chief Commercial Officer | 18,700 0.0162% | $0.49 | $9,172 | +26.92% | |
| 2022-08-15 | Sale | Neils Scott C | Chief Financial Officer | 1,270 0.0011% | $0.48 | $605 | +26.92% | |
| 2018-02-14 | Rizzo Matthew | 945,819 1.3083% | $7.20 | $6.81M | +15.06% | |||
| 2018-02-14 | ORBIMED ADVISORS LLC | 945,819 1.3083% | $7.20 | $6.81M | +15.06% | |||
| 2018-02-14 | Eggenberg Michael | 945,819 1.3083% | $7.20 | $6.81M | +15.06% | |||
| 2016-05-09 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0004% | $2.34 | $11,700 | -64.88% | ||
| 2015-12-03 | Swanson Kent L | director | 2,300 0.0002% | $2.82 | $6,493 | -27.05% | ||
| 2015-12-01 | Swanson Kent L | director | 1,000 <0.0001% | $2.85 | $2,850 | -28.07% | ||
| 2015-11-20 | Kirschman David Louis | EVP & Chief Scientific Officer | 2,000 0.0002% | $2.99 | $5,983 | -28.23% | ||
| 2015-11-20 | Swanson Kent L | director | 4,976 0.0004% | $3.00 | $14,928 | -28.23% | ||
| 2015-11-19 | Kirschman David Louis | EVP & Chief Scientific Officer | 1,000 <0.0001% | $2.94 | $2,943 | -29.19% | ||
| 2015-11-19 | Swanson Kent L | director | 24 <0.0001% | $2.90 | $70 | -29.19% | ||
| 2015-11-18 | Kirschman David Louis | EVP & Chief Scientific Officer | 1,000 <0.0001% | $2.86 | $2,862 | -27.24% | ||
| 2015-11-16 | Goldberger Daniel S | Chief Executive Officer | 3,000 0.0002% | $2.80 | $8,400 | -20.45% | ||
| 2015-09-04 | Goldberger Daniel S | Chief Executive Officer | 81,522 0.0062% | $3.68 | $300,001 | -33.42% |
Insider Historical Profitability
| Brandt Kevin D | Chief Commercial Officer | 815860 0.6271% | $0.63 | 1 | 1 | |
| Rizzo Matthew | 5890884 4.5276% | $0.63 | 1 | 0 | +15.06% | |
| Eggenberg Michael | 5890884 4.5276% | $0.63 | 1 | 0 | +15.06% | |
| ORBIMED ADVISORS LLC | 5890884 4.5276% | $0.63 | 1 | 0 | +15.06% | |
| Vizirgianakis Stavros G. | director | 5850716 4.4967% | $0.63 | 1 | 0 | <0.0001% |
| Kirschman David Louis | EVP & Chief Scientific Officer | 1701063 1.3074% | $0.63 | 3 | 0 | <0.0001% |
| Browne Sean E | President and CEO | 1506584 1.1579% | $0.63 | 0 | 2 | |
| COOK GUY S | 10 percent owner | 1200000 0.9223% | $0.63 | 18 | 31 | <0.0001% |
| Godfrey Mitchell T | director | 711467 0.5468% | $0.63 | 0 | 3 | |
| Neils Scott C | Chief Financial Officer | 403960 0.3105% | $0.63 | 0 | 2 | |
| Goldberger Daniel S | Chief Executive Officer | 86522 0.0665% | $0.63 | 8 | 0 | <0.0001% |
| Swanson Kent L | director | 83128 0.0639% | $0.63 | 8 | 0 | <0.0001% |
| JUDA GREGORY ALEXANDER | Chief Scientific Officer | 40000 0.0307% | $0.63 | 2 | 0 | <0.0001% |
| WICKWIRE JON M. | director | 31247 0.024% | $0.63 | 4 | 0 | |
| DEEDRICK JOHN ARTHUR | director | 16621 0.0128% | $0.63 | 1 | 0 | |
| LOPACH MICHAEL A | director | 14258 0.011% | $0.63 | 2 | 0 | |
| HOLMES DARREL LEE | COO | 11656 0.009% | $0.63 | 0 | 4 | |
| GANDOLFO JOHN P | CFO | 9943 0.0076% | $0.63 | 1 | 0 |
Institutional Investor Ownership
| OrbiMed | $85.54M | 56.15 | 73.11M | 0% | +$0 | 1.75 | |
| Altium Capital Management Lp | $8.95M | 5.87 | 7.65M | -4.73% | -$444,272.38 | 4.16 | |
| Nantahala Capital Management Llc | $4.68M | 3.07 | 4M | 0% | +$0 | 0.48 | |
| The Vanguard Group | $1.81M | 1.19 | 1.55M | +3.22% | +$56,533.23 | <0.0001 | |
| Renaissance Technologies | $893,000.00 | 0.59 | 763,310 | +3.02% | +$26,205.87 | <0.01 | |
| Amh Equity Ltd | $585,000.00 | 0.38 | 500,000 | -15.83% | -$110,013.93 | 0.73 | |
| Awm Investment Company Inc | $442,501.00 | 0.29 | 378,206 | -19.3% | -$105,854.57 | 0.07 | |
| Bridgeway Capital Management | $431,145.00 | 0.28 | 368,500 | 0% | +$0 | 0.01 | |
| Susquehanna International Group | $429,847.00 | 0.28 | 367,391 | +298.02% | +$321,850.27 | <0.0001 | |
| Juniper Investment Company | $407,627.00 | 0.27 | 348,399 | New | +$407,627.00 | 0.2 | |
| Geode Capital Management | $370,048.00 | 0.24 | 316,158 | +20.71% | +$63,500.57 | <0.0001 | |
| Millennium Management LLC | $279,168.00 | 0.18 | 238,605 | +49.74% | +$92,728.40 | <0.0001 | |
| BlackRock | $140,781.00 | 0.09 | 120,326 | -52.94% | -$158,384.77 | <0.0001 | |
| Qube Research & Technologies | $135,191.00 | 0.09 | 115,548 | +8,941.32% | +$133,695.74 | <0.0001 | |
| Citadel Advisors LLC | $76,580.00 | 0.05 | 65,453 | +9.33% | +$6,536.79 | <0.0001 | |
| Northern Trust | $68,639.00 | 0.05 | 58,666 | 0% | +$0 | <0.0001 | |
| Private Advisor Group | $43,875.00 | 0.03 | 37,500 | +275% | +$32,175.00 | <0.0001 | |
| Midwest Professional Planners Ltd | $41,820.00 | 0.03 | 35,744 | 0% | +$0 | 0.02 | |
| Prudential Financial | $33,930.00 | 0.02 | 29,000 | 0% | +$0 | <0.0001 | |
| Jefferies Financial Group | $29,484.00 | 0.02 | 25,200 | New | +$29,484.00 | <0.01 | |
| State Street | $26,051.00 | 0.02 | 22,266 | -32.25% | -$12,401.90 | <0.0001 | |
| Citigroup | $18,676.00 | 0.01 | 15,962 | -74.44% | -$54,398.15 | <0.0001 | |
| JPMorgan Chase | $16,329.00 | 0.01 | 13,956 | +15,941.38% | +$16,227.21 | <0.0001 | |
| Virtu Financial Llc | $17,000.00 | 0.01 | 14,879 | New | +$17,000.00 | <0.01 | |
| UBS | $9,878.00 | 0.01 | 8,443 | +9,077.17% | +$9,770.36 | <0.0001 | |
| Tower Research Capital | $2,647.00 | <0.01 | 2,262 | -78.14% | -$9,462.26 | <0.0001 | |
| Old Point Trust & Financial Service | $2,925.00 | <0.01 | 2,500 | New | +$2,925.00 | <0.01 | |
| Fidelity Investments | $1,324.00 | <0.01 | 1,132 | 0% | +$0 | <0.0001 | |
| Morgan Stanley | $1,492.00 | <0.01 | 1,275 | New | +$1,492.00 | <0.0001 | |
| Wells Fargo | $441.00 | <0.01 | 377 | +1.89% | +$8.19 | <0.0001 | |
| Royal Bank of Canada | $1,000.00 | <0.01 | 514 | New | +$1,000.00 | <0.0001 | |
| Cornerstone Planning Group Llc | $11.00 | <0.01 | 12 | 0% | +$0 | <0.0001 |